Skip to main content

Daniel Kisner, Harry Hixson, Jr., James Burns, Hiroyuki Mitani, Barnstead Genevac, Millipore



Daniel Kisner resigned this week from the board of directors of Sequenom, on which he had served as a member of the audit committee. The board has appointed Harry Hixson, Jr., one of its existing independent directors to fill the vacancy, the company reported.

James Burns was appointed to Ciphergens' board of directors this week, the company said in a statement. Burns is president, CEO, and a director of EntreMed, which he joined in 2004.

Between 2001 and 2003, Burns was served as president and as executive vice president of MedPointe. Prior to that position, he served as a founder and managing director of private equity firm MedPointe Capital Partners. Burns served as a founder, chairman, president, and CEO of Osiris Therapeutics before holding that position. He holds a BS and MS degrees in biological sciences from the University of Illinois and an MBA degree from DePaul University.

Hiroyuki Mitani has been appointed president and CEO of GE Healthcare Technologies, Japan. Mitani joined GE Japan in 1992 as director of business development. Prior to his current role, he served as general manager of marketing and sales for GE Transportation, Japan. In 1996, he served as general manager of marketing and sales for GE Energy, Japan.

Mitani received his MS in operations research from Stanford University in 1984 and an MS in mechanical engineering from the University of California, Berkeley, in 1983. He received his BS in mechanical engineering from the University of Tokyo in 1977.


New Releases

Barnstead Genevac this week launched a new "affordable" miVac centrifugal concentrator with digital temperature control and short concentration times, the company said in a statement.

Millipore launched a new group of compact filtration accessories, the company said this week. The new products include: the Titer Plate Shaker; the Millivac Maxi and Mini Vacuum Pumps, the Chibitan II Personal Centrifuge; and the Milli-Stir Stirring Plate. The new line of products was designed with the goal of producing devices with small footprints.

Filed under

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.